Literature DB >> 23789939

Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Takayuki Kogure1, Yasuteru Kondo, Eiji Kakazu, Masashi Ninomiya, Osamu Kimura, Tooru Shimosegawa.   

Abstract

AIM: Epithelial-mesenchymal transition (EMT) is a crucial process during cancer invasion and metastasis, which is accompanied by the suppressed expression of E-cadherin initiated by stimuli such as transforming growth factor (TGF)-β. Recent studies have shown that the epigenetic regulation of E-cadherin could be an alternate mechanism of EMT induction in hepatocellular carcinoma (HCC). miRNA-29a (miR-29a) is involved in the epigenetic regulation of genes by targeting DNA methyltransferases (DNMT), which methylate CpG islands to suppress the transcription of genes. We studied the involvement of miR-29a in TGF-β-induced EMT in HCC cells.
METHODS: We treated human HCC cell lines with TGF-β to induce EMT. To investigate DNA methylation in EMT, cells were treated with a methylation inhibitor, 5-Aza-2'-deoxycytidine (5-Aza) and methylation status of CpG islands in the E-cadherin promoter was examined using methylation-specific PCR. Precursor miR-29a (pre-miR-29a) was electroporated to force the expression of miR-29a in HCC cells in order to study the role of miR-29a in EMT.
RESULTS: TGF-β transformed HCC cells into a spindle-shaped morphology accompanied by a decrease of E-cadherin with the induction of methylation of its promoter. Pretreatment of the cells with 5-Aza blocked this suppression of E-cadherin, indicating the involvement of DNA methylation. TGF-β increased DNMT3B and DNMT1 and decreased miR-29a expression. The forced expression of miR-29a abrogated the suppression of E-cadherin induced by TGF-β.
CONCLUSION: miR-29a could regulate TGF-β-induced EMT by affecting DNA methylation via the suppression of DNMT. These observations reveal the epigenetic regulation of genes by miRNA as a unique mechanism of EMT in HCC.
© 2013 The Japan Society of Hepatology.

Entities:  

Keywords:  E-cadherin; epithelial-mesenchymal transition; hepatocellular carcinoma; miR-29a

Year:  2013        PMID: 23789939     DOI: 10.1111/hepr.12188

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  20 in total

Review 1.  Connecting the dots: chromatin and alternative splicing in EMT.

Authors:  Jessica A Warns; James R Davie; Archana Dhasarathy
Journal:  Biochem Cell Biol       Date:  2015-07-07       Impact factor: 3.626

2.  The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.

Authors:  Hedyieh Karbasforooshan; A Wallace Hayes; Nooshin Mohammadzadeh; Mohammad Reza Zirak; Gholamreza Karimi
Journal:  Cell Cycle       Date:  2020-11-09       Impact factor: 4.534

3.  miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2.

Authors:  Chunfang Zhao; Ya Li; Ming Zhang; Yi Yang; Li Chang
Journal:  Hum Cell       Date:  2015-01-14       Impact factor: 4.174

Review 4.  Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.

Authors:  Aamir Ahmad; Yiwei Li; Bin Bao; Dejuan Kong; Fazlul H Sarkar
Journal:  Mol Nutr Food Res       Date:  2013-11-24       Impact factor: 5.914

Review 5.  New Tools for Molecular Therapy of Hepatocellular Carcinoma.

Authors:  Alessandra Marchetti; Francesca Bisceglia; Angela M Cozzolino; Marco Tripodi
Journal:  Diseases       Date:  2015-10-30

6.  Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.

Authors:  Megumi Yanokura; Kouji Banno; Masataka Adachi; Daisuke Aoki; Kuniya Abe
Journal:  Int J Oncol       Date:  2017-04-19       Impact factor: 5.650

7.  The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.

Authors:  Rui Wang; Yumei Li; Yueyue Hou; Qingling Yang; Sulian Chen; Xi Wang; Zishu Wang; Yan Yang; Changjie Chen; Zhiwei Wang; Qiong Wu
Journal:  Oncotarget       Date:  2015-03-30

8.  TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells.

Authors:  Zhongxue Ye; Jie Li; Xi Han; Huilian Hou; He Chen; Xia Zheng; Jiaojiao Lu; Lijie Wang; Wei Chen; Xu Li; Le Zhao
Journal:  J Exp Clin Cancer Res       Date:  2016-05-04

9.  MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.

Authors:  Wei-Xun Chen; Zhan-Guo Zhang; Ze-Yang Ding; Hui-Fang Liang; Jia Song; Xiao-Long Tan; Jing-Jing Wu; Guang-Zhen Li; Zhuo Zeng; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2016-04-19

Review 10.  Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.

Authors:  Richard Heery; Stephen P Finn; Sinead Cuffe; Steven G Gray
Journal:  Cancers (Basel)       Date:  2017-04-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.